Sachetta’s Cross Country Healthcare CCRN Stock Holding History

Sachetta’s Portfolio CCRN Stock Details CCRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-38	Closed	-$864	–	1243
2024 Q1	$864	Hold	38	–	–	﹤0.01%	941
2023 Q4	$864	Buy	+38	New	+$824	﹤0.01%	941

Other funds holding CCRN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACB

Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Sachetta's CCRN Position: Q2 2024 in Review

Sachetta sold out of Cross Country Healthcare (CCRN) in Q2 2024, closing a stake of 38 shares — an estimated $864 sold.

Sachetta first reported a position in CCRN in Q4 2023 and held it in 2 quarters. The position peaked at $864 in Q1 2024. 162 funds tracked by Wall St. Rank hold CCRN as of Q2 2024.

Sachetta reported no remaining Cross Country Healthcare position as of Q2 2024 after selling out during the quarter.
Sachetta sold 38 Cross Country Healthcare shares in Q2 2024, an estimated $864.
Sachetta first reported a position in Cross Country Healthcare in Q4 2023 and held it in 2 quarters.
Sachetta's Cross Country Healthcare position peaked at $864 in Q1 2024.
162 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q2 2024.

Based on Sachetta's 13F filing for Q2 2024, filed 7 Aug 2024.